Science Explorer Back to mapMap

Most cited papers from Cardiovascular Research Foundation

What are the most cited papers from Cardiovascular Research Foundation?

The most cited paper from Cardiovascular Research Foundation is "Clinical End Points in Coronary Stent Trials" (Donald E. Cutlip, Stephan Windecker, Roxana Mehran et al., 2007), with 5,449 citations. Next come "Post-acute COVID-19 syndrome" (5,134) and "Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials" (5,070).

Showing 50 of 59 papers. Every paper with more than 626 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Clinical End Points in Coronary Stent Trials Donald E. Cutlip, Stephan Windecker, Roxana Mehran et al. · Circulation 30 Apr 2007 5,449
2 Post-acute COVID-19 syndrome Ani Nalbandian et al. · Nature Medicine Open access 22 Mar 2021 5,134
3 Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials Christian Thomas Ruff, Robert Patrick Giugliano, Eugene Braunwald et al. · The Lancet Review 4 Dec 2013 5,070
4 Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary Artery Jeffrey W. Moses, Martin B. Leon, Jeffrey J. Popma et al. · New England Journal of Medicine Open access Oct 2003 4,242
5 Extrapulmonary manifestations of COVID-19 Aakriti Gupta et al. · Nature Medicine Open access Jul 2020 3,340
6 A Prospective Natural-History Study of Coronary Atherosclerosis Gregg W. Stone, Akiko Maehara, Alexandra J. Lansky et al. · New England Journal of Medicine Open access 19 Jan 2011 3,303
7 Transcatheter Mitral-Valve Repair in Patients with Heart Failure Gregg W. Stone, JoAnn M. Lindenfeld, William T. Abraham et al. · New England Journal of Medicine Open access 23 Sep 2018 2,986
8 COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up Behnood Bikdeli et al. · Journal of the American College of Cardiology Open access 17 Apr 2020 2,956
9 A Polymer-Based, Paclitaxel-Eluting Stent in Patients with Coronary Artery Disease Gregg W. Stone, Stephen G. Ellis, David Alan Cox et al. · New England Journal of Medicine Open access 14 Jan 2004 2,753
10 Initial Invasive or Conservative Strategy for Stable Coronary Disease David Joel Maron et al. · New England Journal of Medicine Open access 30 Mar 2020 2,464
11 A Controlled Trial of Renal Denervation for Resistant Hypertension Deepak L. Bhatt, David E. Kandzari, William W. O’Neill et al. · New England Journal of Medicine 29 Mar 2014 2,192
12 Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic Elissa Driggin, Mahesh V. Madhavan, Behnood Bikdeli et al. · Journal of the American College of Cardiology Open access 19 Mar 2020 2,080
13 A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention Roxana Mehran, Eve D. Aymong, Eugenia Nikolsky et al. · Journal of the American College of Cardiology Open access Oct 2004 2,049
14 Strategies for Multivessel Revascularization in Patients with Diabetes Michael E. Farkouh et al. · New England Journal of Medicine Open access 4 Nov 2012 1,933
15 Bivalirudin during Primary PCI in Acute Myocardial Infarction Gregg W. Stone, Bernhard Witzenbichler, Giulio Guagliumi et al. · New England Journal of Medicine Open access 21 May 2008 1,869
16 Safety and Efficacy of Sirolimus- and Paclitaxel-Eluting Coronary Stents Gregg W. Stone, Jeffrey W. Moses, Stephen G. Ellis et al. · New England Journal of Medicine Open access 12 Feb 2007 1,633
17 Bivalirudin for Patients with Acute Coronary Syndromes Gregg W. Stone et al. · New England Journal of Medicine Open access 22 Nov 2006 1,466
18 Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis Christoph David Stettler et al. · The Lancet Sep 2007 1,432
19 Valve Academic Research Consortium 3: Updated Endpoint Definitions for Aortic Valve Clinical Research Philippe Généreux et al. · Journal of the American College of Cardiology Open access 19 Apr 2021 1,302
20 Comparison of Angioplasty with Stenting, with or without Abciximab, in Acute Myocardial Infarction Gregg W. Stone, Cindy Lee Grines, David Alan Cox et al. · New England Journal of Medicine Open access 28 Mar 2002 1,282
21 A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary interventionDevelopment and initial validation Roxana Mehran, Eve A. Aymong, Eugenia Nikolsky et al. · Journal of the American College of Cardiology 6 Oct 2004 1,274
22 Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation Renato D. Lópes et al. · New England Journal of Medicine Open access 17 Mar 2019 1,223
23 Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials Francesco Costa, David V. Klaveren, Stefan Karl James et al. · The Lancet Open access Mar 2017 1,191
24 Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease Gregg W. Stone et al. · New England Journal of Medicine Open access 31 Oct 2016 1,069
25 Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis Vinod H. Thourani et al. · The Lancet 3 Apr 2016 1,037
26 SCAI clinical expert consensus statement on the classification of cardiogenic shock David Alan Baran, Cindy Lee Grines, Steven R. Bailey et al. · Catheterization and Cardiovascular Interventions Open access 19 May 2019 1,026
27 STS-ACC TVT Registry of Transcatheter Aortic Valve Replacement John D. Carroll, Michael J. Mack, Sreekanth Vemulapalli et al. · Journal of the American College of Cardiology Open access Nov 2020 1,015
28 Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document Héctor M. García‐García, Eugene Patrick McFadden, Andrew A. Farb et al. · Circulation Open access 11 Jun 2018 982
29 Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis Tullio Palmerini, Giuseppe Biondi‐Zoccai, Diego Della Riva et al. · The Lancet 22 Mar 2012 957
30 Transcatheter Aortic Valve Implantation in Failed Bioprosthetic Surgical Valves Danny Dvir et al. · JAMA Open access 8 Jul 2014 921
31 Everolimus-Eluting versus Paclitaxel-Eluting Stents in Coronary Artery Disease Gregg W. Stone, Ali Abbas Rizvi, William N. Newman et al. · New England Journal of Medicine Open access 5 May 2010 901
32 Contrast-induced nephropathy: Definition, epidemiology, and patients at risk Roxana Mehran, Eugenia Nikolsky · Kidney International Open access Apr 2006 896
33 Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study Gregg W. Stone, Bernhard Witzenbichler, Giora Weisz et al. · The Lancet 25 Jul 2013 863
34 Effect of Platelet Inhibition with Cangrelor during PCI on Ischemic Events Deepak L. Bhatt et al. · New England Journal of Medicine Open access 10 Mar 2013 842
35 Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention Philip M. Urban et al. · Circulation Open access 22 May 2019 829
36 In-Stent Restenosis in the Drug-Eluting Stent Era George Dangas, Bimmer E.P.M. Claessen, Adriano Mendes Caixeta et al. · Journal of the American College of Cardiology Open access Nov 2010 813
37 Five-Year Outcomes after PCI or CABG for Left Main Coronary Disease Gregg W. Stone et al. · New England Journal of Medicine Open access 28 Sep 2019 803
38 Impact of Major Bleeding on 30-Day Mortality and Clinical Outcomes in Patients With Acute Coronary Syndromes Steven V. Manoukian, Frederick Feit, Roxana Mehran et al. · Journal of the American College of Cardiology Open access Mar 2007 803
39 Comparison of a Polymer-Based Paclitaxel-Eluting Stent With a Bare Metal Stent in Patients With Complex Coronary Artery Disease Gregg W. Stone, Stephen G. Ellis, Louis Cannon et al. · JAMA 13 Sep 2005 770
40 Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation Kenichi Fujii, STEPHANE G. CARLIER, Gary S. Mintz et al. · Journal of the American College of Cardiology Open access 31 Mar 2005 767
41 Clinical use of intracoronary imaging. Part 1: guidance and optimization of coronary interventions. An expert consensus document of the European Association of Percutaneous Cardiovascular Interventions Lorenz Räber et al. · European Heart Journal Open access 16 May 2018 763
42 Staging classification of aortic stenosis based on the extent of cardiac damage Philippe Généreux et al. · European Heart Journal Open access 18 Jun 2017 752
43 Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data Stuart J. Head et al. · The Lancet Open access 23 Feb 2018 751
44 The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency Luis Gruberg, Gary S. Mintz, Roxana Mehran et al. · Journal of the American College of Cardiology Open access Nov 2000 750
45 Comparison of Propensity Score Methods and Covariate Adjustment Markus C. Elze, John Gregson, Usman Baber et al. · Journal of the American College of Cardiology Open access 2017 729
46 Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial Michel Azizi et al. · The Lancet Open access151 authors 23 May 2018 727
47 Intensive Blood-Pressure Control in Hypertensive Chronic Kidney Disease Lawrence J. Appel et al. · New England Journal of Medicine Open access Sep 2010 721
48 Randomized Trial of a Distal Embolic Protection Device During Percutaneous Intervention of Saphenous Vein Aorto-Coronary Bypass Grafts Donald S. Baim, DENNIS W. WAHR, Barry George et al. · Circulation Open access 19 Mar 2002 714
49 Stent-Based Delivery of Sirolimus Reduces Neointimal Formation in a Porcine Coronary Model Takeshi Suzuki, Greg Kopia, S. Hayashi et al. · Circulation Open access 4 Sep 2001 710
50 A Risk Score to Predict Bleeding in Patients With Acute Coronary Syndromes Roxana Mehran, Stuart Pocock, Eugenia Nikolsky et al. · Journal of the American College of Cardiology Open access Jun 2010 688

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.